Q-SAP Trademark

Trademark Overview


On Monday, March 3, 2025, a trademark application was filed for Q-SAP with the United States Patent and Trademark Office. The USPTO has given the Q-SAP trademark a serial number of 99064286. The federal status of this trademark filing is NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER as of Monday, March 3, 2025. This trademark is owned by Q-VANT Biosciences, Inc.. The Q-SAP trademark is filed in the Pharmaceutical Products category with the following description:

Vaccine adjuvants; Adjuvants for medical purposes; Adjuvants for use with vaccines; Pharmaceutical preparations for the treatment of immune system related diseases and disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Human vaccine preparations; Oral vaccine preparations; Herbal supplements; Drug delivery agents consisting of compounds that facilitate delivery of a wide range of pharmaceuticals; Drug delivery agents in the form of tablets that provide controlled release of the active ingredients for a wide variety of pharmaceuticals; Drug delivery agents in the form of powders that provide controlled release of the active ingredients for a wide variety of pharmaceuticals; Mixed b...
q-sap

General Information


Serial Number99064286
Word MarkQ-SAP
Filing DateMonday, March 3, 2025
Status630 - NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER
Status DateMonday, March 3, 2025
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements


Goods and ServicesVaccine adjuvants; Adjuvants for medical purposes; Adjuvants for use with vaccines; Pharmaceutical preparations for the treatment of immune system related diseases and disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Human vaccine preparations; Oral vaccine preparations; Herbal supplements; Drug delivery agents consisting of compounds that facilitate delivery of a wide range of pharmaceuticals; Drug delivery agents in the form of tablets that provide controlled release of the active ingredients for a wide variety of pharmaceuticals; Drug delivery agents in the form of powders that provide controlled release of the active ingredients for a wide variety of pharmaceuticals; Mixed biological preparations for the prevention and treatment of infectious diseases; Plant extracts, other than essential oils, for pharmaceutical purposes; Plant extracts, other than essential oils, for medical, veterinary and pharmaceutical purposes

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateMonday, March 3, 2025
Primary Code005
First Use Anywhere DateWednesday, March 15, 2023
First Use In Commerce DateWednesday, March 15, 2023

Trademark Owner History


Party NameQ-VANT Biosciences, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressForestdale, MA 02644

Trademark Events


Event DateEvent Description
Monday, March 3, 2025NEW APPLICATION ENTERED
Monday, March 3, 2025NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Monday, March 3, 2025APPLICATION FILING RECEIPT MAILED